Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI
Abstract Challenges remain for clinicians over balancing the efficacy of active antithrombotic therapy and simultaneous bleeding reduction in patients. The clinical data of 347 patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) were retrospectively analyz...
Guardado en:
Autores principales: | Yong-zhe Guo, Zi-wen Zhao, Shu-mei Li, Liang-long Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c428ba58c6174d438a65548fa754bc3d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention
por: Qian Zeng, et al.
Publicado: (2021) -
Safety and Efficacy of Tirofiban During Mechanical Thrombectomy for Stroke Patients with Preceding Intravenous Thrombolysis
por: Huo X, et al.
Publicado: (2020) -
Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis
por: Yun Ho Noh, et al.
Publicado: (2022) -
Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety
por: Zongliang Yu, et al.
Publicado: (2021) -
Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease
por: Ying-Chang Tung, et al.
Publicado: (2020)